Company / Interest Expense per Share
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Interest Expense per Share History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.06
FY2023
5-year range
$0.06 / $0.07
FY2019-FY2023
Trend
-13.6%
vs FY2022
Sector context
#38 of 43
Health Care
What the data says
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s interest expense per share of $0.06 is lower than 88% of companies in the Health Care sector (FY2023). Improved from $0.06 to $0.06 over the past 2 years.
Based on SEC 10-K filings.
0.06 in FY2023 with a 5-year CAGR of +22.1%.
Improved from $0.06 to $0.06 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +233.4%
- 5-Year CAGR
- +22.1%
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 43This company $0.06 Sector average $1.48
▼
-96.2% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share decreased 13.6% year-over-year.
- Ranks #38 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2022.
- Lowest interest expense per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.06 | -13.6% |
| FY2022 | $0.07 | +6.6% |
| FY2021 | $0.06 | +3922.4% |
| FY2020 | $0.00 | -91.1% |
| FY2019 | $0.02 | -17.9% |
| FY2018 | $0.02 | -33.9% |
| FY2017 | $0.03 | -22.0% |
| FY2016 | $0.04 | +20.6% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026